[Treatment of chronic tuberculosis with ethambutol and prothionamide associated with rifomycin of capreomycin].
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D004977:Ethambutol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007539:Isonicotinic Acids / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D007539:Isonicotinic Acids; D004977:Ethambutol; D012293:Rifampin
Traitement de la tuberculose chronique par l'éthambutol et la prothionamide associés à la rifampicine ou la capréomycine.